SCHEMBL30825920

SCHEMBL30825920

O=C1CCc2ccccc2N1n1c(=O)ccc2cccnc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 3/20 0.37
▸ DRD4 P21917 3/20 0.37
▸ DRD3 P35462 3/20 0.37
▸ TSHR P16473 1/20 0.37
▸ GRIN1 Q05586 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CALCRL Q16602 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ USP2 O75604 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ OPRM1 P35372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10581383 0.69 PARP1 (0.37) TSHRKMT2ASMN1; SMN2LMNAMAPT
SCHEMBL29765632 0.63 HPGD (0.59) POLBKMT2AOPRM1OPRK1OPRL1
SCHEMBL29712289 0.63 BRD4 (0.50) TSHRSMN1; SMN2LMNAMAPTCYP2C19
SCHEMBL29311510 0.63 PARP1 (0.42) TSHRSMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL25723262 0.63 CYP2C19 (0.42) TSHRSMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL9577060 0.63 PARP1 (0.46) TSHRSMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL2614748 0.63 BRD4 (0.50) TSHRSMN1; SMN2LMNAMAPTCYP2C19
SCHEMBL3515138 0.63 DAO (0.47) TSHRKMT2ASMN1; SMN2LMNAMAPT
SCHEMBL27254155 0.63 PARP1 (0.42) TSHRSMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL11056945 0.62 CDK4 (0.51) TSHRALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4590396-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF Astrazeneca AB (SE) 2025-07-30 — — EP disclosed
WO-2024062089-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF ASTRAZENECA AB (SE) 2024-03-28 — — WO disclosed
Send feedback